Incidence of symptomatic Covid‐19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population

por Graf, Irene, Herndlhofer, Susanne, Kundi, Michael, Greiner, Georg, Sperr, Martina, Hadzijusufovic, Emir, Valent, Peter, Sperr, Wolfgang R.
Publicado 2022

Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph(+) Chronic Myeloid Leukemia

por Sadovnik, Irina, Ivanov, Daniel, Smiljkovic, Dubravka, Stefanzl, Gabriele, Degenfeld-Schonburg, Lina, Herndlhofer, Susanne, Eisenwort, Gregor, Hauswirth, Alexander W., Sliwa, Thamer, Keil, Felix, Sperr, Wolfgang R., Valent, Peter
Publicado 2022

TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML

por Valent, Peter, Herndlhofer, Susanne, Schneeweiß, Mathias, Boidol, Bernd, Ringler, Anna, Kubicek, Stefan, Gleixner, Karoline V., Hoermann, Gregor, Hadzijusufovic, Emir, Müllauer, Leonhard, Sperr, Wolfgang R., Superti-Furga, Giulio, Mannhalter, Christine
Publicado 2017

Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56(bright) NK cell subpopulations in patients with acute myeloid leukemia and supports their acti...

por Cuapio, Angélica, Post, Mirte, Cerny-Reiterer, Sabine, Gleixner, Karoline V., Stefanzl, Gabriele, Basilio, Jose, Herndlhofer, Susanne, Sperr, Wolfgang R., Brons, Nicolaas H.C., Casanova, Emilio, Zimmer, Jacques, Valent, Peter, Hofer, Erhard
Publicado 2016

Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia

por Heller, G, Topakian, T, Altenberger, C, Cerny-Reiterer, S, Herndlhofer, S, Ziegler, B, Datlinger, P, Byrgazov, K, Bock, C, Mannhalter, C, Hörmann, G, Sperr, W R, Lion, T, Zielinski, C C, Valent, P, Zöchbauer-Müller, S
Publicado 2016

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia

por Cerny-Reiterer, Sabine, Rabenhorst, Anja, Stefanzl, Gabriele, Herndlhofer, Susanne, Hoermann, Gregor, Müllauer, Leonhard, Baumgartner, Sigrid, Beham-Schmid, Christine, Sperr, Wolfgang R, Mannhalter, Christine, Sill, Heinz, Linkesch, Werner, Arock, Michel, Hartmann, Karin, Valent, Peter
Publicado 2014

N‐terminal pro‐brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia

por Graf, Irene, Greiner, Georg, Marculescu, Rodrig, Gleixner, Karoline V., Herndlhofer, Susanne, Stefanzl, Gabriele, Knoebl, Paul, Jäger, Ulrich, Hauswirth, Alexander, Schwarzinger, Ilse, Thalhammer, Renate, Kundi, Michael, Hoermann, Gregor, Mitterbauer‐Hohendanner, Gerlinde, Valent, Peter, Sperr, Wolfgang R.
Publicado 2023

Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics

por Wacheck, Volker, Lahn, Michael, Dickinson, Gemma, Füreder, Wolfgang, Meyer, Renata, Herndlhofer, Susanne, Füreder, Thorsten, Dorfner, Georg, Pillay, Sada, André, Valérie, Burkholder, Timothy P, Akunda, Jacqueline K, Flye-Blakemore, Leann, Van Bockstaele, Dirk, Schlenk, Richard F, Sperr, Wolfgang R, Valent, Peter
Publicado 2011

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1(T315I)+ clones in TKI-resistant CML

por Schneeweiss-Gleixner, Mathias, Byrgazov, Konstantin, Stefanzl, Gabriele, Berger, Daniela, Eisenwort, Gregor, Lucini, Chantal Blanche, Herndlhofer, Susanne, Preuner, Sandra, Obrova, Klara, Pusic, Petra, Witzeneder, Nadine, Greiner, Georg, Hoermann, Gregor, Sperr, Wolfgang R., Lion, Thomas, Deininger, Michael, Valent, Peter, Gleixner, Karoline V.
Publicado 2019

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis

por Schneeweiss, Mathias, Peter, Barbara, Bibi, Siham, Eisenwort, Gregor, Smiljkovic, Dubravka, Blatt, Katharina, Jawhar, Mohamad, Berger, Daniela, Stefanzl, Gabriele, Herndlhofer, Susanne, Greiner, Georg, Hoermann, Gregor, Hadzijusufovic, Emir, Gleixner, Karoline V., Bettelheim, Peter, Geissler, Klaus, Sperr, Wolfgang R., Reiter, Andreas, Arock, Michel, Valent, Peter
Publicado 2018

Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site

por Hadzijusufovic, Emir, Albrecht-Schgoer, Karin, Huber, Kilian, Hoermann, Gregor, Grebien, Florian, Eisenwort, Gregor, Schgoer, Wilfried, Herndlhofer, Susanne, Kaun, Christoph, Theurl, Markus, Sperr, Wolfgang R., Rix, Uwe, Sadovnik, Irina, Jilma, Bernd, Schernthaner, Gerit H., Wojta, Johann, Wolf, Dominik, Superti-Furga, Giulio, Kirchmair, Rudolf, Valent, Peter
Publicado 2017

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia

por Blatt, Katharina, Menzl, Ingeborg, Eisenwort, Gregor, Cerny-Reiterer, Sabine, Herrmann, Harald, Herndlhofer, Susanne, Stefanzl, Gabriele, Sadovnik, Irina, Berger, Daniela, Keller, Alexandra, Hauswirth, Alexander, Hoermann, Gregor, Willmann, Michael, Rülicke, Thomas, Sill, Heinz, Sperr, Wolfgang R., Mannhalter, Christine, Melo, Junia V., Jäger, Ulrich, Sexl, Veronika, Valent, Peter
Publicado 2018